Otter Health Raises $8 Million in Seed Funding
Otter Health, a company focused on transforming utilization management with a provider-first, outcome-focused approach, has successfully raised $8 million in a seed funding round. The funding, announced on October 15, 2026, aims to support the company's mission to save costs, reduce friction, and restore clinical autonomy in the healthcare sector.
Investors and Leadership
The seed round was led by Fika Ventures and Evidenced, with participation from several other investors, including Slow Ventures, Metrodora, CoFound Partners, Layout Ventures, Patient Capital, and Semper Virens. This diverse group of investors reflects broad interest and confidence in Otter Health's innovative approach to healthcare management.
Otter Health is steered by a team of experienced executives. Keith Florance serves as the CEO and Co-Founder, Ram Keralapura holds the position of Co-Founder and Chief Technology Officer, and Will Bartlett is the Co-Founder and Chief Product Officer. Together, they bring a wealth of expertise and vision to the company's operations.
Strategic Use of Funds
While specific details on the use of the funds were not disclosed, it is anticipated that the capital will be used to further develop Otter Health's platform and expand its reach within the healthcare industry. Enhancing technology and improving service offerings are likely priorities as the company works to meet the needs of healthcare providers more effectively.
Location and Company Profile
Otter Health is based in Washington, D.C., United States, a location that positions it strategically at the heart of the nation's healthcare policy and administration.
The successful seed funding round marks a significant step forward for Otter Health as it continues to innovate in the healthcare sector, aiming to streamline processes and improve outcomes for providers and patients alike.